V019-3803 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide

V019-3803 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide
V019-3803 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3803
N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3803

Molecular Formula

C31H31ClN4O4 (C31 H31 ClN4 O4)

Compound Name

N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide

IUPAC name

N-[4-(4-chlorophenyl)-1-(34-dimethoxyphenyl)-1H-imidazol-2-yl]-2-[N-(cyclopropylmethyl)-2-phenylacetamido]acetamide

SMILES

COc(ccc(-n1c(NC(CN(CC2CC2)C(Cc2ccccc2)=O)=O)nc(-c(cc2)ccc2Cl)c1)c1)c1OC

InChI

InChI=1S/C31H31ClN4O4/c1-39-27-15-14-25(17-28(27)40-2)36-19-26(23-10-12-24(32)13-11-23)33-31(36)34-29(37)20-35(18-22-8-9-22)30(38)16-21-6-4-3-5-7-21/h3-7,10-15,17,19,22H,8-9,16,18,20H2,1-2H3,(H,33,34,37)

InChI Key

VVUHJGIGVCKKMN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825140

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

559.06

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.009

Distribution Coefficient, logD

6.009

Water Solubility, LogSw

-6.18

Polar Surface Area

67.649

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

2.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.80

V019-3803 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V019-3803 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3803?
Check Price and Availability of V019-3803, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3803 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3803
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3803
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3803 available by request